"insufficient clinical benefit"
50 patients and insufficient clinical benefit , if they get hundreds of patients over next few years its going to be the same result is it not. $10m cash left is less than a years capital if they need to do more trials. FDA approval would need even more trials.
- Forums
- ASX - By Stock
- Ann: CE Marking Update
"insufficient clinical benefit" 50 patients and insufficient...
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
|
|||||
Last
1.1¢ |
Change
0.001(10.0%) |
Mkt cap ! $41.62M |
Open | High | Low | Value | Volume |
1.1¢ | 1.2¢ | 1.1¢ | $32.12K | 2.919M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 12265078 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 740893 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 12265078 | 0.010 |
23 | 14339583 | 0.009 |
9 | 6767500 | 0.008 |
15 | 7482142 | 0.007 |
8 | 8595000 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 740893 | 4 |
0.012 | 6853579 | 11 |
0.013 | 12939566 | 9 |
0.014 | 7526537 | 10 |
0.015 | 9606380 | 5 |
Last trade - 12.29pm 22/08/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |